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Abstract: Kynurenic acid (KYNA, 4-oxoquinoline-2-carboxylic acid), an intermediate of the trypto-
phan metabolism, has been recognized to exert different neuroactive actions; however, the need of
how it or its aminoalkylated amide derivative N-(2-(dimethylamino)ethyl)-3-(morpholinomethyl)-4-
oxo-1,4-dihydroquinoline-2-carboxamide (KYNA-A4) exerts any effects on ion currents in excitable
cells remains largely unmet. In this study, the investigations of how KYNA and other structurally
similar KYNA derivatives have any adjustments on different ionic currents in pituitary GH3 cells and
hippocampal mHippoE-14 neurons were performed by patch-clamp technique. KYNA or KYNA-A4
increased the amplitude of M-type K+ current (IK(M)) and concomitantly enhanced the activation time
course of the current. The EC50 value required for KYNA- or KYNA-A4 -stimulated IK(M) was yielded
to be 18.1 or 6.4 µM, respectively. The presence of KYNA or KYNA-A4 shifted the relationship of
normalized IK(M)-conductance versus membrane potential to more depolarized potential with no
change in the gating charge of the current. The voltage-dependent hysteretic area of IK(M) elicited
by long-lasting triangular ramp pulse was observed in GH3 cells and that was increased during
exposure to KYNA or KYNA-A4. In cell-attached current recordings, addition of KYNA raised the
open probability of M-type K+ channels, along with increased mean open time of the channel. Cell
exposure to KYNA or KYNA-A4 mildly inhibited delayed-rectifying K+ current; however, neither
erg-mediated K+ current, hyperpolarization-activated cation current, nor voltage-gated Na+ current
in GH3 cells was changed by KYNA or KYNA-A4. Under whole-cell, current-clamp recordings, ex-
posure to KYNA or KYNA-A4 diminished the frequency of spontaneous action potentials; moreover,
their reduction in firing frequency was attenuated by linopirdine, yet not by iberiotoxin or apamin.
In hippocampal mHippoE-14 neurons, the addition of KYNA also increased the IK(M) amplitude
effectively. Taken together, the actions presented herein would be one of the noticeable mechanisms
through which they modulate functional activities of excitable cells occurring in vivo.
Keywords: kynurenic acid; kynurenic acid derivative; M-type K+ current; action potential; pituitary
cell; hippocampal neuron
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1. Introduction
Kynurenic acid (KYNA) is a naturally occurring product of the normal metabolism
of amino acid L-tryptophan that has been reported to inhibit NMDAR and neuronal
nicotinic α7 receptors [1–4]. This compound, together with L-kynurenine, is thought
to be an endogenous metabolite of L-tryptophan known to block N-methyl-D-aspartate
receptor (NMDAR), and it has been frequently demonstrated to exert neuroprotective
or anticonvulsant properties in the brain [2,3,5–13]. This compound has been indeed
disclosed to inhibit NMDARs at the glycine-binding site and it can noncompetitively
inhibit α7-nicotinic acetylcholine receptor, and through this action, it might modulate
glutamate release presynaptically [1,3,14,15].
Earlier studies have demonstrated that the reduction in the astrocytic formation of
KYNA could enhance glutamatergic tone in the hippocampus as well as cognitive abilities
and synaptic plasticity [8]. KYNA is also thought to be a target molecule in neuroen-
docrinology [11]. The KYNA derivatives have been also increasingly noticed to exert
various biological actions [10,16,17]. For example, as administered systemically, KYNA-A4
was previously reported to decrease population spike activity recorded from the pyramidal
layer of area CA1 of the hippocampus [10]. However, the issue of how KYNA and other
structurally similar compounds exert any perturbations on voltage-activated ionic currents
in electrically excitable membrane is not yet thoroughly investigated, although previous
experiments have reported the effectiveness of KYNA in modulating the magnitude of
KCNQ gene- (KCNQ)- or HCN gene- (HCN)-encoded current [18,19].
The KCNQ2, KCNQ3, or KCNQ5 gene is recognized to encode the core subunit of
KV7.2, KV7.3 or KV7.5 channel, respectively. The enhanced activity of these voltage-gated
K+ channels can generate the macroscopic M-type K+ current (IK(M)), which is biophysically
manifested by current activation in response to low-threshold voltage and, once activated,
the current displays a slowly activating and deactivating property [20–26]. Targeting IK(M)
is noticeably viewed as an adjunctive regimen for the management of various neurological
or endocrine disorders associated with neuronal over-excitability, which include cognitive
dysfunction, neuropathic pain, and epilepsy [27–30]. Alternatively, previous studies have
demonstrated that KYNA-mediated vasodilation and hypotension could be attributed to
the activation of KCNQ channels [18,31].
In light of the above-stated considerations, in the present study, we wanted to evaluate
the possible underlying mechanisms of KYNA or its structurally similar compound KYNA-
M1(3-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-2-carboxylic acid) or KYNA-A4 (N-(2-
(dimethylamino)ethyl)-3-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-2-carboxamide) (Fig-
ure 1) on the perturbing actions on different types of voltage-gated ionic currents (e.g., IK(DR)
[delayed-rectifier K+ current], IK(M), Ih [hyperpolarization-activated cation current], and INa
[voltage-gated Na+ current]) in pituitary GH3 or R1220 cells and in hippocampal mHippoE-14
neurons.
Figure 1. Chemical structures of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic
acid) and its amide derivatives (KYNA-M1, [3-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-
2-carboxylic acid] and KYNA-A4, [N-(2-(dimethylamino)ethyl)-3-(morpholinomethyl)-4-oxo-1,4-
dihydroquinoline-2-carboxamide]).
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2. Results
2.1. Effect of KYNA and KYNA Derivatives (i.e., KYNA-M1 and KYNA-A4) on M-Type K+
Current (IK(M)) in GH3 Cells
In the first stage, we determined whether the IK(M) inherently in GH3 cells [21,25,32,33]
can be subject to being modified by these compounds. As illustrated in Figure 2A,B, after
1 min of continuous exposure of cells to 10 or 30 µM KYNA caused a progressive increase
in the amplitude of IK(M) activated by long-lasting membrane depolarization. For example,
KYNA at a concentration of 30 µM, IK(M) evoked by 1-s step depolarization from −50 to
−10 mV was increased to 82± 8 pA (n = 8, p < 0.05) from a control value of 39± 7 pA (n = 8).
The value of the activation time constant of IK(M) was concomitantly reduced from 141± 23
to 67 ± 12 ms (n = 8, p < 0.05). After washout of the agent, current amplitude returned to
41 ± 7 pA (n = 7, p < 0.05). Amide derivative of KYNA (KYNA-M1) also led to the raise
in IK(M) amplitude to a similar magnitude (data not shown), while KYNA-A4, another
KYNA derivative was noticed to increase current amplitude more potently. Meanwhile,
the IK(M) functionally expressed in another pituitary cells (i.e., R1220 cells) was sensitive to
stimulation by KYNA.
Figure 2. Effect of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) and N-(2-(dimethylamino)ethyl)-3-
(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-2-carboxamide (KYNA-A4) on M-type K+ current (IK(M)) recorded from
GH3 cells. In these experiments, we kept cells to be bathed in high-K+, Ca2+-free solution, and the recording electrode was
backfilled with K+-containing internal solution. (A) Representative current traces obtained in the control (a), during cell
exposure to 10 µM KYNA (b) or 30 µM KYNA (c), and after washout of KYNA (d). The insert shows the voltage-clamp
protocol applied, while the dashed line is zero-current level. (B) Concentration-dependent stimulation of KYNA () or
KYNA-A4 (#) on the amplitude of IK(M) (i.e., linopirdine-sensitive current) (mean ± SEM; n = 7). Current amplitudes
during the exposure to different concentrations (1 µM to 1 mM) of KYNA or KYNA-A4 were taken at the end of the 1-s
depolarizing pulse from −50 to −10 mV, and the amplitudes were then compared with those measured after subsequent
addition of linopirdine (10 µM). The smooth lines with which the experimental data are overlaid were derived with the
goodness-of-fitness test by the modified Hill equation detailed under Section Materials and Methods.
The association between the KYNA or KYNA-A4 concentration and the percentage
increase in IK(M) was further determined. Of notice, KYNA or KYNA-A4 was able to raise
the amplitude of IK(M) in a concentration-dependent manner (Figure 2B). In the presence of
KYNA or KYNA-A4, the least-squares fit to the modified Hill equation, as described under
Section Materials and Methods, yielded 18.1 or 6.4 µM, respectively, as the concentration
required for half-maximal stimulation (i.e., EC50) was determined. Therefore, the emerging
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data reflect that the magnitude of changes in IK(M) stimulated by KYNA-A4 tends to be
higher than that by KYNA.
2.2. Steady-State Activation Curve of IK(M) in the Absence and Presence of KYNA or KYNA-A4 in
GH3 Cells
We next studied whether the activation curve of IK(M) (i.e., the IK(M)-conductance
versus membrane potential) can be modified by the presence of KYNA or KYNA-A4.
As illustrated in Figure 3, the relation of IK(M) conductance versus membrane potential
obtained in the control (i.e., KYNA or KYNA-A4 was not present) and during exposure
to KYNA or KYNA-A4 was constructed and then analyzed. The sigmoidal curve derived
from data sets was optimally fitted with the modified Boltzmann equation (described under
Section Materials and Methods). That is, the values of V1/2 taken in the control, during cell
exposure to 30 µM KYNA and 30 µM KYNA-A4 were−14.2± 1.8 mV,−18.1± 1.8 mV, and
−23.2 ± 1.9 mV (n = 7), respectively, while those of the gating charge (i.e., q) in the control,
in the presence of 30 µM KYNA and 30 µM KYNA-A4 were 5.9 ± 0.2 e, 6.0 ± 0.2 e and
6.0± 0.3 e (n = 7), respectively. The emerging data thus enable us to disclose that, aside from
the increase in IK(M) conductance, the presence of KYNA (30 µM) or KYNA-A4 (30 µM)
was capable of causing a leftward shift along the voltage axis, despite ineffectiveness of
these compounds in modifying the gating charge of the current.
Figure 3. Effect of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) and N-(2-
(dimethylamino)ethyl)-3-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-2-carboxamide (KYNA-
A4) on the activation curve of IK(M) in GH3 cells. In this set of current recordings, as the whole-cell
mode was firmly established, we voltage-clamped the cell at -50 mV and a series of step commands
ranging between -50 and 0 mV in 10-mV increments was applied. The relationship of conductance
versus membrane potential was demonstrated in the absence (•) and presence of 30 µM KYNA (∆)
or 30 µM KYNA-A4 () (mean ± SEM; n = 7). Inset shows the voltage-clamp protocol used.
2.3. Effect of KYNA on Voltage-Dependent Hysteresis of IK(M) Elicited by Long
Isosceles-Triangular Ramp Pulse
The voltage hysteresis of ionic currents (i.e., a lag in the current magnitude as the
linear voltage command is changed in the opposite direction) has been demonstrated with
a notable impact on the electrical signal events of different excitable cells [25,34–37]. In
other words, hysteretic behavior is thought to dynamically adjust the voltage sensitivity
and kinetics to optimize channel function for matching its physiological role. An urge was,
therefore, made to determine how the presence of KYNA is able to adjust the strength
of such hysteresis occurring in IK(M). In this separate set of experiments, as soon as the
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whole-cell configuration was established, we held the examined cell in voltage clamp at
−50 mV, and a long-lasting upright isosceles-triangular ramp pulse with a duration of 3.4 s
(i.e., a ramp slope of ±35 mV/s) was designed and, through digital-to-analog conversion,
thereafter delivered at a rate of 0.025 Hz. Of interest, as depicted in Figure 4, the trajectories
of IK(M) activated by the forward upsloping (i.e., voltage change from −60 to 0 mV) ramp
pulse and by the backward downsloping (i.e., the change from 0 to −60 mV) as a function
of time (as indicated by the dashed arrows in Figure 4A) were overly distinct between
these two limbs. In other words, the IK(M) amplitude elicited by the upsloping (forward)
limb of the triangular voltage ramp was demonstrated to be smaller than that responding
to the downsloping (backward) limb of the ramp. These observations indicate that there
was a voltage-dependent hysteresis ranging between −30 and 0 mV for this type of current
in these cells. The strength of the voltage hysteresis was further quantified on the basis of
the difference in the area under the curvilinear trajectory in the forward (upsloping) and
reverse (downsloping) direction. Figure 4B illustrates a summary of the area under the
curve (i.e., ∆area indicated in the shaded area) between the forward and backward currents
activated in response to a 3.4-s isosceles-triangular ramp pulse. Of note, as the whole-cell
IK(M) was established, the addition of 10 or 30 µM KYNA increased the area up to 4- or
10-fold, respectively, while the presence of 10 µM linopirdine, a well-known inhibitor
of IK(M) or KM channels [24,25], alone decreased the area by around 60%. Subsequent
addition of 10 µM linopirdine, still in the presence of 30 µM KYNA, attenuated KYNA-
induced increase of such hysteretic area. It is conceivable, therefore, that voltage-dependent
hysteresis of IK(M) in these cells can be enlarged by the presence of KYNA.
Figure 4. Effect of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) on the voltage-dependent hysteresis of
IK(M) identified from GH3 cells. Cells were bathed in high-K+, Ca2+-free solution, and the electrode was backfilled with
K+-containing solution. (A) Representative current traces in the absence (left) or presence of 30 µM KYNA (right). Current
traces were elicited in response to 3.4-s long isosceles-triangular ramp voltage command (indicated in Inset of the right
panel). The dashed arrows in each panel indicate the direction of current trajectory in which time passes (—: forward;
—: backward). (B) Summary bar graph depicting the effects of KYNA (10 or 30 µM) or KYNA (30 µM) plus linopirdine
(10 µM, Lino) on the ∆area (indicated in the shaded area of (A)) of the voltage hysteresis (mean ± SEM; n = 8 for each bar).
* indicates a significant difference from control (p < 0.05) and † indicates significant difference from the KYNA (30 µM) alone
group (p < 0.05).
2.4. Effect of KYNA on M-Type K+ Channel (KM) Channels Recorded from GH3 Cells
The KYNA-stimulated whole-cell IK(M) observed above could arise from changes in
either channel open probability, unitary amplitude, or gating kinetics of the KM channel.
The reasons therefore urged us to examine the single-channel recording of the channel. In
these cell-attached current recordings, we suspended cells in high-K+, Ca2+-free solution,
Int. J. Mol. Sci. 2021, 22, 1300 6 of 20
and the recording electrode was filled with low-K+ (5.4 mM) solution. As illustrated in
Figure 5, when the examined cell was maintained at 0 mV, the activity of single-KM channel
was robustly detected [32]. As KYNA was applied to the bath, the channel open proba-
bility was progressively raised. For example, the presence of 30 µM KYNA significantly
increased the channel open probability from 0.021 ± 0.006 to 0.058 ± 0.008 (n = 8, p < 0.05);
however, minimal change in the single-channel amplitude was demonstrated. The mean
open time of KM channels was concurrently lengthened to 6.1 ± 0.3 ms (n = 7, p < 0.05)
from a control value of 3.2 ± 0.2 ms (n = 7). Moreover, in the continued presence of
KYNA, further application of either linopirdine, bisoprolol, or dapagliflorizin was able to
decrease KYNA-enhanced probability of KM-channel openings significantly. Bisoprolol
and dapagliflorizin were previously reported to inhibit IK(M) amplitude [32,38].
Figure 5. Effect of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) on single channel activity of M-type K+
(KM) channels identified in GH3 cells. In these current recordings, we bathed cells in high-K+, Ca2+-free solution and the
recording electrode was backfilled with low-K+ (5.4 mM) solution, the composition of which is stated in Section Materials
and Methods. (A) Original single KM channels obtained in the control (a), during exposure to 10 µM KYNA (b) or 30 µM
KYNA (c), and after application of 30 µM KYNA plus 10 µM linopirdine (d). The potential was held at 0 mV relative to
the bath. The opening event of the channel is indicated as the upward deflection. (B) Summary bar graph showing effects
of KYNA (10 or 30 µM), KYNA (30 µM) plus linopirdine (Lino, 10 µM), KYNA (30 µM) plus bisoprolol (Bis, 10 µM) and
KYNA (30 µM) plus dapagliflorizin (Dapa, 10 µM) on the channel opening probability of KM channels recorded from GH3
cells (mean ± SEM; n = 7 for each bar). Channel activity was measured at 0 mV relative to the bath. * indicates a significant
difference from control (i.e., KYNA was not present) (p < 0.05), while † indicates significant difference from KYNA (30 µM)
alone group (p < 0.05).
2.5. Effect KYNA on Delayed-Rectified K+ Current (IK(DR)) in Pituitary Tumor (GH3) Cells
In the next stage of the experiments, we evaluated possible perturbations of KYNA on
IK(DR) in these cells. To record IK(DR), cells were bathed in Ca2+-free Tyrode’s solution which
contained tetrodotoxin (TTX, 1 µM) and CdCl2 (0.5 mM), and the recording pipette was
filled up with K+-containing solution. Tetrodotoxin (TTX) or CdCl2 was used to block Na+
or Ca2+ currents, respectively, while Ca2+-free Tyrode’s solution used as bathing solution
was to avoid any contamination of Ca2+-activated K+ currents [25,39]. When the examined
cell was maintained in voltage clamp at −50 mV and a series of voltage pulses ranging
from −50 to +60 mV in 10-mV increments with a duration of 1 s was applied, a family of
the outwardly directed K+ currents was elicited (Figure 6A,B). These outward currents,
which displayed an outwardly rectifying property with fast activation and deactivation
kinetics, were sensitive to block by tetraethylammonium (TEA), but not by iberiotoxin or
apamin, and was identified as IK(DR) [39]. Iberiotoxin or apamin is the blocker of the large-
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or small-conductance Ca2+-activated K+ channels, respectively. When cells were exposed
to KYNA (30 µM), the amplitude of the outwardly directed IK(DR) in response to membrane
depolarization was reduced with little or no concurrent change in current inactivation.
For example, when the examined cells were depolarized from −50 to +50 mV, KYNA at
a concentration of 10 µM decreased the current amplitude by 26 ± 3 % from 917 ± 99
to 683 ± 68 pA (n = 12). After washout of the agent, current amplitude was returned to
892 ± 93 pA (n = 11). The current-voltage (I-V) relationship of IK(DR) with or without
addition of KYNA was constructed and is then illustrated in Figure 6B, indicating that
the presence of this compound mildly inhibited the amplitude of IK(DR). Additionally, it
was noticed that the current amplitudes at the voltages ranging between −50 and −10 mV
were increased in the presence of KYNA. Figure 6Bb depicts an I-V relationship of KYNA-
sensitive current (i.e., difference between current amplitude obtained in the absence and
presence of 30 µM KYNA). The enhanced current amplitude obtained at the voltage below
0 mV was attenuated by further addition of linopirdine (10 µM), reflecting that, under
these experimental conditions, the component appears to belong to IK(M) that is stimulated
by KYNA.
Figure 6. Effect of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) on delayed-rectifier K+ current (IK(DR)) in
GH3 cells. The experiments were undertaken in cells bathed in Ca2+-free, Tyrode’s solution, and we filled up the electrode
with K+-containing solution. (A) Representative current traces obtained in the control (upper) and during cell exposure to
30 µM KYNA. The voltage-clamp profile was demonstrated in the uppermost part. (Ba) Mean I-V relations of IK(DR) taken
in the absence () and presence (#) of 30 µM KYNA (mean ± SEM; n = 8 for each point). Current amplitude was taken at
each depolarizing pulse from a holding potential of −50 mV. Panel (Bb) shows an expanded graph from (Ba), while the
arrow indicates a crossover point between these two I-V curves.
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2.6. Lack of KYNA on Erg-Mediated K+ Current (IK(erg))
In the next set of experiments, we examined whether KYNA could perturb different
types of voltage-gated K+ current (e.g., IK(erg)). In these current recordings, we kept cells
in high-K+, Ca2+-free solution, and the cell was held in voltage clamp at −10 mV and
the 1-s hyperpolarizing pulse to −100 mV was applied to evoke the inwardly directed
IK(erg), which is sensitive to block by thyrotropin releasing hormone (1 µM) [40]. As
illustrated in Figure 7A,B, the application of KYNA (30 µM) resulted in no change in IK(erg)
amplitude. The mean I-V relationship of IK(erg) amplitude measured at different levels of
1-s hyperpolarizing pulses taken with or without KYNA (30 µM) addition was depicted in
Figure 7B. For example, as the cell was 1-s depolarized from -10 to -100 mV, IK(erg) obtained
in the control (i.e., KYNA was not present) was measured to be 686 ± 47 pA (n = 8), a value
that did not differ significantly from that in the presence of 30 µM KYNA (687 ± 49 pA,
n = 8, p > 0.05). Moreover, as cells were continually exposed to 30 µM KYNA, subsequent
addition of E-4031 (10 µM) resulted in a significant reduction of deactivating IK(erg) in
response to membrane hyperpolarization (Figure 7B). Therefore, unlike IK(M) or IK(DR), the
IK(erg) in GH3 cells is resistant to any adjustments by KYNA.
Figure 7. Lack of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) effect of erg-mediated K+ current (IK(erg)).
In this set of experiments, we kept cells in high-K+, Ca2+-free solution and the electrode was backfilled with K+-containing
solution. (A) Representative current traces (i.e., the inwardly directed IK(erg)) obtained in the control (a) and during exposure
to 30 µM KYNA (b) or 30 µM KYNA plus 10 µM E-4031 (c). The upper part shows the voltage-clamp protocol used to evoke
IK(erg). (B) Mean I-V relationships of IK(erg) obtained in the absence () of 30 µM KYNA (#) or 30 µM KYNA plus 10 µM
E-4031 (∆) (mean ± SEM; n = 7 for each point). Current amplitude was measured at the beginning of each hyperpolarizing
pulse. Of notice, the overall I-V relationship of IK(erg) between the absence and presence of KYNA (30 µM) did not differ.
2.7. Inability of KYNA to Modify Hyperpolarization-Activated Cation Current (Ih)
Previous work has demonstrated the ability of KYNA to decrease the amplitude of Ih
or heart rate [15,19,41]. For these reasons, we further investigated whether the presence of
KYNA could perturb the amplitude and gating of Ih in GH3 cells [42]. In these experiments,
cells were bathed in Ca2+-free, Tyrode’s solution and we filled up the electrode by using
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K+-containing solution. When the whole-cell configuration was achieved, we held the
cell in voltage clamp at −40 mV and a 2-s hyperpolarizing pulse was applied to evoke
the inwardly directed Ih with a slowly activating time course (Figure 8A,B). As GH3 cells
were exposed to 30 µM KYNA, the Ih amplitude at the level of −110 mV was not changed
(121 ± 17 pA (in the control) versus 122 ± 18 pA (in the presence of 30 µM KYNA); n = 8,
p > 0.05). However, in the continued presence of 30 µM KYNA, further addition of 10 µM
cilobradine was able to decrease Ih amplitude to 41 ± 11 pA (n = 8, p < 0.05). Cilobradine
was previously reported to block Ih [43]. Mean I-V relationship of Ih amplitude obtained
in the absence and presence of KYNA or KYNA plus 10 µM cilobradine is illustrated in
Figure 8B. It is therefore reasonable to assume that the Ih in GH3 cells tends to be resistant
to KYNA.
Figure 8. Lack of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) effect on the hyperpolarization-activated
cation current (Ih) recorded from GH3 cells. The whole-cell current recordings were conducted in cells bathed in Ca2+-free,
Tyrode’s solution containing 1 µM TTX and 0.5 mM CdCl2, and the recording electrode was filled up with K+-containing
solution. (A) Representative current traces obtained in the control (a, KYNA was not present), and during exposure to
KYNA (30 µM) (b) or to KYNA (30 µM) plus cilobradine (Cil, 10 µM) (c). The upper part is the voltage-clamp protocol
delivered. (B) Mean I-V relationship of Ih taken in the absence () and presence of KYNA (30 µM) (#) or KYNA (30 µM)
plus cilobradine (Cil, 10 µM) (∆) (mean ± SEM; n = 8 for each point). Current amplitude was taken at the end of 2-s
hyperpolarizing pulse to a series of voltages ranging between −110 and −40 mV from a holding potential of −40 mV. Of
notice, there is void of KYNA effect on the amplitude or time course of Ih evoked throughout the entire voltage-clamp steps
examined; however, further addition of cilobradine, still in the presence of KYNA, can decrease Ih amplitude effectively.
2.8. Ineffectiveness of KYNA in Modifying Voltage-Gated Na+ Current (INa) in GH3 Cells
Riluzole is recognized to be an antagonist of NMDA receptors and beneficial for
the management of amyotrophic lateral sclerosis [6]. It was previously demonstrated to
inhibit INa effectively in skeletal muscle cells [44]. For these reasons, we further extended
to explore whether KYNA is able to produce any effects on INa. In this set of current
recordings, we bathed cells in Ca2+-free, Tyrode’s solution containing 10 mM TEA, and
the recording electrode was backfilled with Cs+-containing solution. As the whole-cell
mode was achieved, we voltage-clamped the cell at a holding potential of −80 mV and the
rapid depolarizing pulse to −10 mV was applied to evoke INa in these cells. As illustrated
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in Figure 9, cell exposure to 30 µM KYNA produced minimal changes in the amplitude
of INa. However, the inability of 30 µM KYNA to decrease peak amplitude of INa was
demonstrated (1.7 ± 0.3 nA (in the control) versus 1.7 ± 0.3 nA (in the presence of 30 µM
KYNA); n = 7, p > 0.05). Moreover, as cells were continually exposed to 30 µM KYNA, a
further addition of TTX (1 µM) or columbianadin (10 µM) decreased peak INa amplitude to
0.30 ± 0.04 nA (n = 7, p < 0.05) or 0.55 ± 0.05 nA (n = 7, p < 0.05), respectively; however,
that of tefluthrin raised peak INa to 2.2 ± 0.30 nA (n = 7, p < 0.05). Columbianadin was
a bioactive coumarin-type compound reported to inhibit INa [45], while tefluthrin was
previously reported to activate INa [46]. As such, the presence of KYNA was unable to
modify the amplitude and gating of INa identified in GH3 cells.
Figure 9. Inability of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) to perturb the amplitude or gating of
voltage-gated Na+ current (INa) in GH3 cells. In these whole-cell experiments, cells were kept to be immersed in Ca2+-free,
Tyrode’s solution containing 10 mM TEA and 0.5 mM CdCl2, while we filled up the electrode with Cs+-containing internal
solution. (A) Representative INa traces taken in the control (i.e., KYNA was not present, a) and during cell exposure to
30 µM KYNA (b) or 30 µM KYNA plus 1 µM TTX (c). The voltage-clamp protocol used to elicit INa is depicted in the upper
part. (B) Summary bar graph showing effects of KYNA, KYNA plus TTX, KYNA plus columbianadin (CBN, 10 µM), or
KYNA plus tefluthrin (Tef, 10 µM). Each bar represents the mean ± SEM (n = 7). * indicates a significant difference from
KYNA (30 µM) alone group (p < 0.05).
2.9. Effect of KYNA or KYNA-A4 on Spontaneous Action Potentials (APs) Recorded from
GH3 Cells
In another separate series of experiments, we wanted to explore whether the presence
of KYNA or KYNA-A4 and the related compounds perturb any changes in membrane
potential in these cells. We kept the examined cells to be bathed in normal Tyrode’s solution
containing 1.8 mM CaCl2 and the recording pipette was filled with K+-containing solution.
As illustrated in Figure 10A,B, when the current-clamp voltage recordings were achieved,
spontaneous APs with a firing frequency of 0.77 ± 0.06 Hz (n = 7) were robustly detected.
Of notice, as GH3 cells were exposed to KYNA, the cell membrane became progressively
hyperpolarized and the firing frequency was concurrently decreased, as demonstrated by
a significant reduction in the firing frequency to 0.42 ± 0.04 Hz (n = 7, p < 0.05) during
exposure to 30 µM KYNA. In the continued presence of 30 µM KYNA, further application
of neither iberiotoxin nor apamin had any effects on spontaneous APs; however, that of
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10 µM linopirdine did significantly reverse KYNA-mediated decrease of firing frequency to
0.65± 0.06 Hz (n = 7, p < 0.05). Similar results were also found in the presence of KYNA-A4
(3 or 10 µM) (Figure 10Bb). It is therefore conceivable from these results that the observed
effect of KYNA or KYNA-A4 on the firing patterns of GH3 cells could be explained by its
stimulation of IK(M).
Figure 10. Effect of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) and N-(2-(dimethylamino)ethyl)-
3-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-2-carboxamide (KYNA-A4) on spontaneous action potentials (APs)
recorded from GH3 cells. In this set of the experiments, cells were bathed in normal Tyrode’s solution, the electrode was filled
with K+-containing solution, and the whole-cell current-clamp voltage recordings were performed. (A) Original potential
traces obtained in the control (a) and during exposure to 10 µM KYNA (b) or 30 µM KYNA (c). In (B), (Ba) illustrates
summary bar graph depicting effects of KYNA (10 or 30 µM), KYNA (30 µM) plus iberiotoxin (Iber, 200 nM), KYNA (30 µM)
plus apamin (Apa, 200 nM), and KYNA (30 µM) plus linopirdine (Lino, 10 µM) on the frequency of spontaneous APs in
GH3 cells, while (Bb) shows those of KYNA-A4 (3 or 10 µM), KYNA-A4 (10 µM) plus Iber (200 nM), KYNA-A4 (10 µM)
plus Apa (200 nM), and KYNA-A4 (10 µM) plus Lino (10 µM) on firing frequency. Each bar indicates the mean ± SEM
(n = 7). * indicates a significant difference from controls (p < 0.05) and † indicates significant difference from KYNA (30 µM)
or KYNA-A4 (10 µM) alone group (p < 0.05).
2.10. Effect of KYNA and KYNA Plus Linopirdine on IK(M) Measured from Hippocampal
mHippoE-14 Neurons
In a final stage of experiments, we further tested whether the IK(M) present in different
types of excitable cells (e.g., hippocampal mHippoE-14 neurons) is sensitive to adjustments
by KYNA. Cells were bathed in high-K+, Ca2+-free solution and the electrode used was
filled with K+-containing internal solution. As whole-cell configuration was established,
we maintained the examined cell in voltage clamp at -50 mV and the depolarizing pulse to
-10 mV with a duration was applied to evoke IK(M) [47,48]. The high-K+, Ca2+-free solution
used as the extracellular solution in these experiments is to minimize the contamination of
Ca2+-activated K+ channels in these cells [47]. As illustrated in Figure 11, as mHippoE-14
cells were exposed to 30 µM KYNA, the IK(M) amplitude was increased to 54 ± 8 pA
(n = 7, p < 0.05) from a control value of 31 ± 4 pA (n = 7). In the continued presence of
30 µM KYNA, subsequent addition of linopirdine (10 µM) was effective in attenuating
KYNA-stimulated IK(M) in these cells, as demonstrated by a significant reduction of current
amplitude to 34 ± 5 pA (n = 7, p < 0.05). Meanwhile, the presence of 30 µM KYNA-A4
increased IK(M) amplitude from 31 ± 4 to 72 ± 9 pA (n = 7, p < 0.05). Therefore, similar to
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the experimental results described in GH3 cells, IK(M) amplitude in response to membrane
depolarization was sensitive to simulation by KYNA in mHippoE-14 neurons.
Figure 11. Effect of kynurenic acid (KYNA, 4-hydroxyquinoline-2-carboxylic acid) on IK(M) identified from hippocampal
mHippoE-14 neurons. For this set of current recordings, we kept cells immersed in high-K+, Ca2+-free solution containing
1 µM TTX, and we thereafter backfilled the electrode with K+-containing internal solution. (A) Representative current traces
activated by membrane depolarization from -50 to -10 mV with a duration of 1 s. The dashed line shows zero-current
level. a: control; b: 30 µM KYNA; c: 30 µM KYNA plus 10 µM linopirdine (Lino). (B) Summary bar graph showing effect
of KYNA (30 µM) or KYNA (30 µM) plus linopirdine (Lino, 10 µM) on the IK(M) amplitude recorded from mHippoE-14
neurons (mean ± SEM; n = 7 for each bar). Current amplitudes taken in the absence and presence of KYNA or KYNA plus
linopirdine were measured at the end of 1-s depolarizing pulse from −50 to −10 mV. * indicates a significant difference
from control (p < 0.05) and † indicates significant difference from KYNA (30 µM) alone group (p < 0.05).
3. Discussion
In this study, we provide the evidence to disclose that in pituitary GH3 cells, KYNA
or KYNA-A4 produces a stimulatory effect on IK(M) in a concentration-, voltage-, and
state-dependent fashion. On the basis of the concentration-dependent relationship (i.e., the
modified Hill equation), the value of EC50 required for KYNA- or KYNA-A4-mediated
stimulation of IK(M) identified from GH3 cells were calculated to be 18.1 or 6.4 µM, respec-
tively. The EC50 value of KYNA-stimulated IK(M) appeared to be lower than that for its
inhibition of NR1a/NR2A receptors or AMPA-evoked currents [7]. The relationship of
IK(M)-conductance versus membrane potential taken in the presence of KYNA (30 µM) or
KYNA-A4 (30 µM) was noticed to produce a leftward shift along the voltage axis by about
4 or 9 mV, respectively. As such, there is anticipated to be a pertinent link between its
effects on endocrine or neuroendocrine cells and the stimulatory effect on IK(M). However,
whether such differential action by KYNA and KYNA-A4 on IK(M) could occur the in vivo
studies needs to be further resolved.
In addition to the increased IK(M) amplitude, KYNA or KYNA-A4 was able to shorten
the activation time constant of the current. Stimulation of IK(M) caused by KYNA thus does
not become instantaneous, yet it develops with time once the KM-channels are opened upon
membrane depolarization, thereby leading to an apparent increase in current activation. In
keeping with these observations, single-channel current recordings were found to prolong
mean open time of KM channels in the presence of KYNA. In this scenario, the increase
in both probability openings and mean open times of KM channels produced by KYNA
or its amide derivatives would be mainly responsible for its increase of macroscopic IK(M)
amplitude carried through these channels, despite their ineffectiveness in changing the
single-channel amplitude. In this regard, KYNA or its structurally similar compounds (e.g.,
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KYNA-A4) would be expected to be valuable tools for probing the structure and function
of KM channels [16,17,49].
In accordance with previous observations [25], the voltage-dependent hysteresis of
IK(M) in response to the long isosceles-triangular ramp pulse was demonstrated in GH3
cells. The strength of such hysteretic perturbations was recently described to serve a role
in tuning the activity of KM channels to respond as they are needed [37]. We also further
determined the possible adjustments of KYNA on such non-equilibrium property of IK(M)
present in GH3 cells. The data reflected that the presence of KYNA allowed for an increase
in the hysteretic strength efficiently (i.e., ∆area indicated in the shaded area of Figure 4A)
linked to the voltage-dependent activation of IK(M). Therefore, it is possible that intrinsic
changes in the voltage dependence of the voltage sensing machinery of KM channels (i.e.,
voltage-sensing domain relaxation) would be dynamically adjusted during exposure to
KYNA or its derivatives [25,35].
Distinguishable to some extent from previous studies reflecting the effectiveness of
KYNA in decreasing the amplitude of Ih or heart rate [15,19,41], in the present study, we
were unable to observe any adjustments of KYNA or KYNA-A4 on the amplitude and
gating of Ih activated by long-lasting membrane hyperpolarization. However, as GH3 cells
were continually exposed to KYNA, a further addition of ivabradine effectively suppressed
the amplitude of Ih. Ivabradine was known to be an inhibitor of HCN-encoded current [50].
It is therefore possible that KYNA-induced analgesia tends to be indirectly associated
with its changes in Ih amplitude and that it could be better explained by its activation
of IK(M). Moreover, unlike the effect of flupirtine, known to be an activator of IK(M), on
IK(DR) described previously in motoneuron-like cells [51], the inactivation kinetics of IK(DR)
remained unchanged during exposure to KYNA or KYNA-A4, although flupirtine could
inhibit the amplitude of IK(DR).
Because of its polar structure, KYNA is thought to have poor CNS penetration. How-
ever, its precursor kynurenine, which easily crosses the blood-brain-barrier, is rapidly
transported into astrocytes upon entry into the brain. Once formed in the astrocytes, KYNA
can be readily released into the extracellular milieu [2]. Alternatively, recent studies have
shown that the synthetic amide derivatives of KYNA (e.g., KYNA-A4) investigated in this
study could readily cross the barrier [10,16,49]. In our study, the addition of KYNA was
noted to activate IK(M) effectively in hippocampal mHippoE-14 neurons. It is therefore
reasonable to propose that these derivatives through their stimulation of IK(M) could be
beneficial for the treatment of different psychiatric or neurological disorders [2,5,8,11].
KYNA has been reported to be an antagonist of NMDA receptor [12]. Earlier work
has reflected that addition of glutamate could depolarize pituitary cells and facilitate Ca2+
influx from the exterior [52,53]. Glutamate-mediated Ca2+ rise was also demonstrated to
be attenuated by further addition of KYNA [53]. However, L-glutamate (1 mM) alone did
not affect IK(M) amplitude in GH3 cells; moreover, as L-glutamate (1 mM) was continually
present, the subsequent addition of KYNA or KYNA-A4 still effectively increased IK(M)
in GH3 cells. We also observed that KYNA or KYNA-A4 depressed the firing frequency
of spontaneous APs, thereby leading to the reduction of cytosolic Ca2+. Therefore, it is
possible that the stimulatory effect of these agents on IK(M) seen in GH3 cells is attributed
to be in great part the result of an interaction with the KM channel. Whether KYNA-
or KYNA-A4-stimulated IK(M) is mediated through the elicitation of G protein(s) (e.g.,
G-protein-coupled orphan receptor (GPR35)) [9,19,54,55] remains to be resolved, since it
was previously reported that the voltage-dependent activity of IK(M) could be modulated
by phosphatidylinositol 4,5-bisphosphate (PIP2) [20,56]. Alternatively, the functional
expression of GPR35 has not been thus far reported in pituitary lactotrophs.
KYNA-A4 is more effective in stimulating IK(M) than KYNA or KYNA-M1, although
none of them could perturb IK(erg), Ih or INa. It therefore appears that in the KYNA molecule,
the tertiary nitrogen containing amide side-chain (N,N-dimethylaminoethyl-amide group
at position 2) could enhance the activation of IK(M) in GH3 cells, possibly owing to the less
polar properties of KYNA-A4 as compared with those in KYNA. Nonetheless, the decreased
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firing of APs caused by these compounds detected in GH3 cells could be attributed to the
stimulation of IK(M) [32]. However, it needs to be mentioned that the inhibition by these
compounds of IK(DR) in these cells might partly contribute to their effectiveness in their
perturbations on spontaneous APs with high frequency, since it can lessen the strength of
resurgent K+ currents [57]. Of also note, awareness needs to be strengthened in attributing
its aberrant use to the antagonistic effect on the NMDAR activity [8,12,14,15,53,58].
Previous studies have demonstrated that kynurenine, thought to be an endothelium-
derived relaxing factor, can relax blood vessel possibly through the activation of adenylate
cyclase [59]. However, in this study, in the continued presence of either KYNA or KYNA-
M1, subsequent application of 2′-5′-dideoxyadenosine (10 µM), a cell-permeable inhibitor
of adenylate cyclase, did not attenuate its stimulation of IK(M) in GH3 cells, although further
application of thyrotropin releasing hormone (1 µM) did reverse it. Therefore, it seems
unlikely that the activation of IK(M) caused by these two agents is mediated through their
adjustments in the activity of adenylate cyclase.
It should also be mentioned that in some of electrophysiological recordings, KYNA
(i.e., around 300 µM) had been put into the bathing solution for tissues or cells studied, in
attempts to preclude any possible interference with excitatory glutaminergic neurotrans-
mission appearing in the preparations [60–66]. Under this scenario, the experiments results
could have been ambiguous (i.e., either under- or over-emphasized) owing possibly to the
direct actions on ionic currents (e.g., the overstimulation of IK(M)) presented herein.
In light of the present findings, the perturbations by KYNA or KYNA-A4 on the
amplitude and gating of IK(M) provide an insight through which they modulate functional
activities in excitable cells.
4. Materials and Methods
4.1. Drugs, Chemicals, and Solutions Used in This Study
Kynurenic acid (KYNA, 4-oxoquinoline-2-carboxylic acid, C10H7NO3), 2′,5′-
dideoxyadenoine, cilobradine (Cil, DK-AH269), L-glutamate, linopirdine, ODQ (1H-[1,2,4]
oxadiazolol-[4,3a] quinoxalin-1-one), tefluthrin (Tef) tetraethylammonium chloride (TEA),
tetrodotoxin (TTX), and thyrotropin releasing hormone were acquired from Sigma-Aldrich
(Merck, Taipei, Taiwan), while iberiotoxin and apamin were obtained from Alomone (Yu
Shing Bio-Tech, Taipei, Taiwan), E-4031 was from Enzo (Blossom Biotechnologies, Taipei,
Taiwan), bisoprolol was from Tocris (Union Biomed, Taipei, Taiwan), and columbianadin
(CBN) and dapagliflozin (DAPA) were from Cayman (Asia Bioscience, Taipei, Taiwan).
KYNA amide derivative (e.g., 3-(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-2-
carboxylic acid, C15H16N2O4, [KYNA-M1], and N-(2-(dimethylamino)ethyl)-3-
(morpholinomethyl)-4-oxo-1,4-dihydroquinoline-2-carboxamide, C19H26N4O3, [KYNA-
A4] were synthesized at Institute of Pharmaceutical Chemistry, University of Szeged,
Szeged, Hungary according to literature methods [17]. The chemical structures of KYNA,
KYNA-M1, and KYNA-A4 are illustrated in Figure 1. Culture media (e.g., Ham’s F-12
medium), horse or fetal calf serum, L-glutamine, and trypsin/EDTA were acquired from
HyCloneTM (Thermo Fisher; Level Biotech, Tainan, Taiwan), whereas other chemicals,
including CdCl2, CsCl, CsOH, aspartic acid, and HEPES, were of the best available quality,
mostly at analytical grade.
The composition of extracellular solution (i.e., HEPES-buffered normal Tyrode’s so-
lution) was as follows (in mM): NaCl 136.5, KCl 5.4, CaCl2 1.8, MgCl2 0.53, glucose 5.5,
and HEPES-NaOH buffer 5 (pH 7.4). To record either membrane potential or the current
through IK(M), IK(erg) or Ih, the recording electrodes used were backfilled with the following
solution (in mM): K-aspartate 130, KCl 20, KH2PO4 1, MgCl2 1, EGTA 0.1, Na2ATP 3,
Na2GTP 0.1, and HEPES-KOH buffer 5 (pH 7.2). To record current through IK(M) or IK(erg),
we used high K+-bathing solution containing the following (in mM): KCl 145, MgCl2 0.53,
and HEPES-KOH buffer 5 (pH 7.4). To measure the activity of single KM channels, the
pipette solution was composed of the following (in mM): NaCl 136.5, KCl 5.4, MgCl2 0.53,
and HEPES-NaOH buffer 5 (pH 7.4). All solutions were prepared using deionized water
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from a Milli-Q water purification system (Merck Millipore, Taipei, Taiwan). The pipette
solution and culture media were filtered on the day of use with Acrodisc® syringe filter
with Supor® membrane (0.22 µm in pore size) (Bio-Check, New Taipei City, Taiwan).
4.2. Cell Preparations
GH3 pituitary tumor cells, acquired from the Bioresources Collection and Research
Center ((BCRC, catalog number: 60015); Hsinchu, Taiwan; originally derived from the
American Type Culture Collection (ATCC® (CCL-82.1TM, catalog number: 82.1)), were
cultured in Ham’s F-12 medium supplemented with 2.5% fetal calf serum (v/v percent), 15%
horse serum (v/v percent), and 2 mM L-glutamine at 37 ◦C in a humidified environment
of 5% CO2/95% air. Rat pituitary cells (#R1220) were purchased from ScienCell Research
Laboratories, Inc., (Excel Biomedical, Tainan, Taiwan). R1220 cells reported to express
the receptors of gonadotropin releasing hormone (GnRH) were originally isolated from
neonate day-8 CD® rats and cryopreserved in primary cultures with further purification
and expansion [67]. They were grown in Epithelial Cell Medium (catalog number: 4101;
ScienCell).
The embryonic mouse hippocampal cell line (mHippoE-14, CLU198) was obtained
from Cedarlane CELLutions Biosystems, Inc. (Hycell International Co.; Taipei, Taiwan).
Cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum (v/v percent) and 2 mM L-glutamine. Culture medium was changed ev-
ery two or three days, and cells underwent passed when they reached confluence. The
experiments were performed 5 or 6 days after cells had been cultured (60–80% confluence).
4.3. Electrophysiological Measurements
Shortly before the experiments, we dissociated cells (i.e., GH3, R1220 or mHippoE-14
cells) and transferred an aliquot of cell suspension to a custom-made recording chamber
mounted on the stage of DM-IL inverted fluorescence microscope (Leica; Major Instruments,
Kaohsiung, Taiwan). We bathed cells at room temperature (20–25 ◦C) in HEPES-buffered
normal Tyrode’s solution, the composition of which is stated above. The electrodes were
prepared from Kimax-51 capillaries (#34500 [1.5–18 mm in outer diameter]; Kimble, Dogger,
New Taipei City, Taiwan) by either a P-97 Flaming/Brown puller (Sutter, Novato, CA, USA)
or a Narishige PP-830 puller (Narishige; Major Instruments, New Taipei City, Taiwan), and
we then fire-polished their tips with MF-83 microforge (Narishige). As filled with different
internal solutions, their resistances ranged from 3 to 5 MΩ. Recordings of membrane
potential or ionic currents were measured in the whole-cell or cell-attached configuration
of the standard patch-clamp technique with an RK-400 patch amplifier (Bio-Logic, Claix,
France) [68]. The liquid junction potentials were zeroed shortly before giga-seal formation
was made, and the whole-cell data were corrected.
4.4. Data Recordings
The signals containing both potential and current traces were stored online in an
Acer SPIN-5 touchscreen display computer (SP513-52N-55WE; Taipei, Taiwan) at 10 kHz
connected to Digidata 1440A interface (Molecular Devices; Bestogen Biotech, New Taipei
City, Taiwan), which was used for efficient analog-to-digital/digital-to-analog conversion.
During the recordings, the latter device was operated by pCLAMP 10.7 software (Molecular
Devices) run under Windows 10 (Redmond, WA, USA), and the signals were simultane-
ously displayed on an LCD monitor through USB type-C connection. Current signals
were low-pass filtered at 2 kHz with FL-4 four-pole Bessel filter (Dagan, Minneapolis,
MN, USA) to minimize background noise. As high-frequency stimuli were necessarily
applied, an Astro-med Grass S88X pulse stimulator (Grass, West Warwick, RI, USA) was
employed. After the data were digitally collected, we off-line analyzed them using various
analytical tools that include LabChart 7.0 program (ADInstruments; Gerin, Tainan, Taiwan),
OriginPro 2016 (OriginLab; Schmidt Scientific, Kaohsiung, Taiwan) and custom-created
macros run under Microsoft Excel® 2016 (Redmond, WA, USA).
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4.5. Data Analyses
To determine the percentage increase of KYNA or KYNA-A4 on IK(M), current ampli-
tude at the concentration of 1 mM KYNA or KYNA-A4 taken as 100%, and those during
exposure to varying KYNA or KYNA-M1 concentrations (1 µM–1 mM) were analyzed
and compared. To measure IK(M), we kept cells bathed in high-K+, Ca2+-free solution, and
the depolarizing voltage command from −50 to −10 mV was applied. The IK(M) ampli-
tude during the application of KYNA or KYNA-A4 were compared with those measured
after subsequent addition of linopirdine (10 µM). The concentration-response data for
stimulation of IK(M) were thereafter least-squares fitted to the modified Hill equation (i.e.,
multi-parameter logistic equation). That is,




where [C] represents the KYNA or KYNA-A4 concentration applied; Emax is the maximal
stimulation of IK(M) (i.e., linopirdine-sensitive current) caused by KYNA or KYNA-A4; and
nH or EC50 is the Hill coefficient or the concentration of KYNA or KYNA-A4 required for
50% stimulation, respectively.
The relationship between the membrane potentials and the IK(M) conductance obtained
with and without the application of KYNA (30 µM) or KYNA-A4 (10 µM) was appropriately








where Gmax denotes the maximal conductance of IK(M), V1/2 is the voltage at which half-
maximal activation of the current is achieved, q is the apparent gating charge, F is Faraday’s
constant, R is the universal gas constant, and T is the absolute temperature.
4.6. Analyses of Single M-Type K+ (KM) Channels
Single KM-channel currents recorded from GH3 cells were analysis using pCLAMP
10.7 program. We evaluated single-channel amplitude obtained with or with the addition
of KYNA or KYNA-M1 by fitting Gaussian distributions to the amplitude histograms of
the closed (resting) or open state. The probabilities of KM channel that would be open were
defined N·PO, which was estimated using the following expression:
N × PO =
A1 + 2A2 + 3A3 + 4A4 + . . . + nAn
A0 + A1 + A2 + A3 + . . . An
(3)
where N is the number of active KM-channels in the patch examined, A0 the area under the
curve of an all points histogram corresponding to the closed (resting) state, and A1. . . An the
histogram area that indicate the level of distinct open state for 1 to n channels in the patch.
The single-channel conductance of KM channels was calculated using a linear regression
with mean values of single-channel amplitudes measured at different level of membrane
potentials relative to the bath.
4.7. Statistical Analyses
Linear or nonlinear (e.g., Hill or Boltzmann equation and single exponential) curves
fitting to data sets demonstrated here were performed from the goodness-of-fit test using
either Microsoft Excel 2016 (Redmond, WA, USA) or 64-bit OriginPro 2016 (OrignLab).
The values are provided as means ± standard error of mean (SEM) with sample sizes (n),
which indicate the number of cells collected. The Student’s t-test (paired or unpaired) or
one-way analysis of variance followed by post-hoc Fisher’s least-significance difference
test for multiple-range comparisons, were implemented for the statistical evaluation of
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difference among means. Probability with p < 0.05 was considered statistically significant,
unless noted otherwise.
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Abbreviations
AP Action potential
EC50 The concentration required for 50% stimulation
HCN channel Hyperpolarization-activated cyclic nucleotide-gated ion channel
Ih Hyperpolarization-activated cation current
IK(DR) Delayed-rectifier K+ current
I-V Current versus voltage
IK(erg) Erg-mediated K+ current
IK(M) M-type K+ current
INa Voltage-gated Na+ current
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